{
    "2020-07-02": [
        [
            {
                "time": "",
                "original_text": "医药中期策略：迎接后疫情时代 医药优先看好“5+X”",
                "features": {
                    "keywords": [
                        "医药",
                        "中期策略",
                        "后疫情时代",
                        "5+X"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "创业板指翻绿，迈瑞医疗、深信服等跌幅居前",
                "features": {
                    "keywords": [
                        "创业板指",
                        "翻绿",
                        "迈瑞医疗",
                        "深信服",
                        "跌幅居前"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技",
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}